Assessment of Drug-Induced QTc Prolongation in Mental Health Practice: Validation of an Evidence-Based Algorithm

References

• de Mooij LD, Kikkert M, Theunissen J, et al. Dying too soon: excess mortality in severe mental illness. Front Psychiatry. 2019;10:855. doi:10.3389/fpsyt.2019.00855
   PubMed Web of Science ®Google Scholar
• Correll CU, Solmi M, Veronese N, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017;16(2):163–180. doi:10.1002/wps.20420
   PubMed Web of Science ®Google Scholar
• Ringen PA, Engh JA, Birkenaes AB, Dieset I, Andreassen OA. Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions. Front Psychiatry. 2014;5:137. doi:10.3389/fpsyt.2014.00137
   PubMed Web of Science ®Google Scholar
• Risgaard B, Waagstein K, Winkel BG, et al. Sudden cardiac death in young adults with previous hospital-based psychiatric inpatient and outpatient treatment: a nationwide cohort study from Denmark. J Clin Psychiatry. 2015;76(9):e1122–9. doi:10.4088/JCP.14m09742
   PubMed Web of Science ®Google Scholar
• Vohra J. Sudden cardiac death in schizophrenia: a review. Heart Lung Circ. 2020;29(10):1427–1432. doi:10.1016/j.hlc.2020.07.003
   PubMed Web of Science ®Google Scholar
• Girardin F, Sztajzel J. Cardiac adverse reactions associated with psychotropic drugs. Dialogues Clin Neurosci. 2007;9(1):92–95.
   Google Scholar
• Buckley NA, Sanders P. Cardiovascular adverse effects of antipsychotic drugs. Drug Saf. 2000;23(3):215–228. doi:10.2165/00002018-200023030-00004
   PubMed Web of Science ®Google Scholar
• Glassman AH, JT B Jr. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry. 2001;158(11):1774–1782. doi:10.1176/appi.ajp.158.11.1774
   PubMed Web of Science ®Google Scholar
• Stöllberger C, Huber JO, Finsterer J. Antipsychotic drugs and QT prolongation. Int Clin Psychopharmacol. 2005;20(5):243–251. doi:10.1097/01.yic.0000166405.49473.70
   PubMed Web of Science ®Google Scholar
• Al-Khatib SM, Allen LaPointe NM, Kramer JM, et al. A survey of health care practitioners’ knowledge of the QT interval. J Gen Intern Med. 2005;20(5):392–396. doi:10.1111/j.1525-1497.2005.0101.x
   PubMed Web of Science ®Google Scholar
• Fongemie JM, Al-Qadheeb NS, Estes NA, et al. Agreement between ICU clinicians and electrophysiology cardiologists on the decision to initiate a QTc-interval prolonging medication in critically ill patients with potential risk factors for torsade de pointes: a comparative, case-based evaluation. Pharmacotherapy. 2013;33(6):589–597. doi:10.1002/phar.1242
   PubMed Web of Science ®Google Scholar
• Daniel NM, Walsh K, Leach H, Stummer L. Implementation of a QTc-interval monitoring protocol by pharmacists to decrease cardiac risk in at-risk patients in an acute care inpatient psychiatric facility. Ment Health Clin. 2019;9(2):82–87. doi:10.9740/mhc.2019.03.082
   PubMedGoogle Scholar
• Khatib R, Sabir FRN, Omari C, Pepper C, Tayebjee MH. Managing drug-induced QT prolongation in clinical practice. Postgrad Med J. 2021;97(1149):452–458. doi:10.1136/postgradmedj-2020-138661
   PubMed Web of Science ®Google Scholar
• Lambiase PD, de Bono JP, Schilling RJ, et al. British heart rhythm Society clinical practice guidelines on the management of patients developing QT Prolongation on antipsychotic medication. Arrhythm Electrophysiol Rev. 2019;8(3):161–165. doi:10.15420/aer.2019.8.3.G1
   PubMed Web of Science ®Google Scholar
• Zolezzi M, Cheung L. A literature-based algorithm for the assessment, management, and monitoring of drug-induced QTc prolongation in the psychiatric population. Neuropsychiatr Dis Treat. 2019;15:105–114. doi:10.2147/NDT.S186474
   PubMed Web of Science ®Google Scholar
• Zolezzi M, Elhakim A, Elamin WM, et al. Content validation of an algorithm for the assessment, management and monitoring of drug-Induced QTc prolongation in the psychiatric population. Neuropsychiatr Dis Treat. 2021;17:3395–3405. doi:10.2147/NDT.S334350
   PubMed Web of Science ®Google Scholar
• Almanasreh E, Moles R, Chen TF. Evaluation of methods used for estimating content validity. Res Social Adm Pharm. 2019;15(2):214–221. doi:10.1016/j.sapharm.2018.03.066
   PubMed Web of Science ®Google Scholar
• Zamanzadeh V, Ghahramanian A, Rassouli M, Abbaszadeh A, Alavi-Majd H, Nikanfar AR. Design and implementation content validity study: development of an instrument for measuring patient-centered communication. J Caring Sci. 2015;4(2):165–178. doi:10.15171/jcs.2015.017
   PubMedGoogle Scholar
• Polit DF, Beck CT, Owen SV. Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Res Nurs Health. 2007;30(4):459–467. doi:10.1002/nur.20199
   PubMed Web of Science ®Google Scholar
• McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22:276–282. doi:10.11613/BM.2012.031
   PubMed Web of Science ®Google Scholar
• Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20(1):37–46. doi:10.1177/001316446002000104
   Web of Science ®Google Scholar
• Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–174. doi:10.2307/2529310
   PubMed Web of Science ®Google Scholar
• Tisdale JE, Jaynes HA, Kingery JR, et al. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes. 2013;6(4):479–487. doi:10.1161/CIRCOUTCOMES.113.000152
   PubMed Web of Science ®Google Scholar
• CredibleMeds® Crediblemeds.org. CredibleMeds: home [Internet]; 2013. Avalable from: www.crediblemeds.org. Accessed June 21, 2023.
   Google Scholar
• Funk MC, Beach SR, Bostwick JR, et al. QTc prolongation and psychotropic medications. Am J Psychiatry. 2020;177(3):273–274. doi:10.1176/appi.ajp.2019.1760501
   PubMed Web of Science ®Google Scholar
• Schwartz PJ, Woosley RL, Crotti L. When prescribing drugs, do medical doctors and healthcare professionals realize that their patient has the long QT syndrome? Eur Heart J. 2019;40(37):3118–3120. doi:10.1093/eurheartj/ehz355
   PubMed Web of Science ®Google Scholar
• Woosley RL, Black K, Heise CW, Romero K. CredibleMeds.org: what does it offer? Trends Cardiovasc Med. 2018;28(2):94–99. doi:10.1016/j.tcm.2017.07.010
   PubMed Web of Science ®Google Scholar
• Al-Khatib SM, Stevenson WG, Ackerman MJ. 2017 AHA/ACC/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart rhythm Society. J Am Coll Cardiol. 2018;72(14):e91–e220. doi:10.1016/j.jacc.2017.10.054
   PubMed Web of Science ®Google Scholar
• Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. ESC Scientific Document Group. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997–4126. doi:10.1093/eurheartj/ehac262
   PubMed Web of Science ®Google Scholar
• Botstein P. Is QT interval prolongation harmful? A regulatory perspective. Am J Cardiol. 1993;72(6):50B–52B. doi:10.1016/0002-9149(93)90041-A
   PubMed Web of Science ®Google Scholar
• Taylor DM, Barnes TRE, Young AH. The Maudsley Prescribing Guidelines in Psychiatry. 13th ed. John Wiley & Sons; 2018.
   Google Scholar